Lung cancer is classified into two major categories: non-small cell lung cancer (NSCLC), which accounts for 85% of lung cancer cases, and small-cell lung cancer (SCLC), which accounts for the ...

Small cell lung cancer (SCLC) is a fast-growing cancer that forms in the lung. It's one of two types of lung cancer. The other type is non-small cell lung cancer (NSCLC). SCLC is less common than ...

Lung cancer in general, and non-small cell lung cancer (NSCLC) in particular, is often asymptomatic in the early stages of the disease. When symptoms do occur in an early stage (e.g., endobronchial ...

Lung adenocarcinoma is the most common type of lung cancer diagnosed in the U.S. Just over half of all non-small-cell lung cancers (NSCLCs) are adenocarcinomas. Finding out that you're at risk of lung ...

Results of a new study conclude that a pathology tool powered by artificial intelligence can predict whether a patient with extensive-stage small cell lung cancer will respond to platinum-based ...

The American College of Chest Physicians (CHEST) recently released a new clinical guideline on the management of patients with early-stage non-small cell lung cancer (NSCLC). Published in the journal ...

Lung (pulmonary) sarcoma is a rare type of cancer that forms in the blood vessels and supportive tissue in your lungs. Most lung cancers, including small cell and non small cell lung cancers, are ...

Understanding the patterns of acquired resistance to epidermal growth factor receptor (EGFR) TKI treatment has led to more effective combination therapy and continues to drive development of novel ...

Scientists used CRISPR to disable the NRF2 gene, restoring chemotherapy sensitivity in lung cancer cells and slowing tumor growth. The technique worked even when only a fraction of tumor cells were ...